HealthDay (10/11, Murez) reports, “The U.S. Food and Drug Administration is warning consumers about risks of using compounded versions of the drug ketamine, often taken for psychiatric disorders.” Such drugs “are not evaluated by the FDA for safety and effectiveness. They’re also not regulated like approved drugs, so they present a greater risk.” Compounded ketamine products are increasingly being used “for mental health disorders including depression, anxiety, PTSD and obsessive-compulsive disorder, according to the FDA.” However, in a statement, the FDA said, “Despite increased interest in the use of compounded ketamine, we are not aware of evidence to suggest that it is safer, is more effective, or works faster than medications that are FDA-approved for the treatment of certain psychiatric disorders.”
Related Links:
— “FDA Warns of Dangers of Compounded Ketamine for Psychiatric Use,”Cara Murez, HealthDay, October 11, 2023